SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-003325
Filing Date
2020-05-05
Accepted
2020-05-05 16:01:13
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050520p.htm 10-Q 432136
2 EXHIBIT 31.1 exh_311.htm EX-31.1 10668
3 EXHIBIT 31.2 exh_312.htm EX-31.2 10755
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3624
5 EXHIBIT 32.2 exh_322.htm EX-32.2 3636
12 GRAPHIC logo.jpg GRAPHIC 9776
  Complete submission text file 0001171843-20-003325.txt   2969823

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE apto-20200331.xml EX-101.INS 513364
7 XBRL SCHEMA FILE apto-20200331.xsd EX-101.SCH 43780
8 XBRL CALCULATION FILE apto-20200331_cal.xml EX-101.CAL 29001
9 XBRL DEFINITION FILE apto-20200331_def.xml EX-101.DEF 253944
10 XBRL LABEL FILE apto-20200331_lab.xml EX-101.LAB 223504
11 XBRL PRESENTATION FILE apto-20200331_pre.xml EX-101.PRE 281051
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 20848727
SIC: 2836 Biological Products, (No Diagnostic Substances)